Clinical Trial Results

DC Longitudinal Study on Aging and Specimen Bank

N/AOBSERVATIONAL Washington D.C., District of Columbia

RECRUITING

Late Onset Alzheimer's Disease

N/AOBSERVATIONAL Washington D.C., District of Columbia +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

PHASE2INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Clinical Trial on Agitation in Alzheimer's Dementia

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

PHASE1INTERVENTIONAL Bethesda, Maryland

RECRUITING

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

PHASE1INTERVENTIONAL Bethesda, Maryland

RECRUITING

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

PHASE3INTERVENTIONAL Chandler, Arizona +4 more

RECRUITING

Open-label Extension Study in Participants With Early Alzheimer's Disease

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

PHASE3INTERVENTIONAL Chandler, Arizona +4 more

RECRUITING

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Crownlands Observing Progression With Neurons Study

N/AOBSERVATIONAL Germantown, Maryland

RECRUITING

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

PHASE2INTERVENTIONAL Baltimore, Maryland

RECRUITING

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

EARLY_PHASE1INTERVENTIONAL Baltimore, Maryland

RECRUITING

Vestibular Therapy in Alzheimer's Disease

NAINTERVENTIONAL Baltimore, Maryland

RECRUITING

Music Therapy for Patients With Alzheimer's Disease

NAINTERVENTIONAL Baltimore, Maryland

RECRUITING

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

NAINTERVENTIONAL Baltimore, Maryland

RECRUITING

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

PHASE2INTERVENTIONAL Baltimore, Maryland

RECRUITING

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

NAINTERVENTIONAL Baltimore, Maryland

RECRUITING

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

N/AOBSERVATIONAL Baltimore, Maryland

RECRUITING